Colon Cancer

Why trials studying Colon Cancer stopped, in this sample of ClinicalTrials.gov.

17 stopped trials with a clear reason; 94% ended for non-scientific reasons.

Trials

• Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME)
  NCT05900648 · WITHDRAWN · slow enrollment
  “0 participant accrual”
• Does Genetic Susceptibility for Bleeding Affect Quantitative Faecal Immunochemical Test (qFIT) Results?
  NCT05329870 · WITHDRAWN · staffing, sites or logistics
  “never started due to funding/staffing issues”
• The PAI Trial for Breast and Colon Cancer Survivors
  NCT05156463 · WITHDRAWN · staffing, sites or logistics
  “Award not yet received and PI is transferring to a different institution”
• OMega-3 Fatty Acid for the Immune Modulation of Colorectal Cancer
  NCT03661047 · WITHDRAWN · slow enrollment
  “Study will be closed due to zero enrollment in over 2 years.”
• Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
  NCT03745326 · TERMINATED · slow enrollment
  “Study was closed due to lack of accrual and study outcomes overlapped with another protocol's eligibility.”
• A Study of Niclosamide in Patients With Resectable Colon Cancer
  NCT02687009 · TERMINATED · slow enrollment
  “low accrual”
• TVB 2640 for Resectable Colon Cancer Other Resectable Cancers; a Window Trial.
  NCT02980029 · TERMINATED · slow enrollment
  “Study was terminated by the PRMC for low accrual”
• RCT of Mobile Apps & FitBit v. Usual Care
  NCT03623464 · SUSPENDED · other
  “Study is paused for interim analysis.”
• L-Menthol Injection as a Novel Technique During Colonoscopy
  NCT02588248 · TERMINATED · funding or business
  “Sponsor/Investigator has decided to close out the study”
• Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
  NCT03014284 · WITHDRAWN · funding or business
  “Military collaborator sample supplier was transferred, no samples obtained”
• Mechanistic Prehabilitation
  NCT01919541 · WITHDRAWN · slow enrollment
  “difficulty in recruiting patients”
• Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
  NCT01347645 · TERMINATED · funding or business
  “The study was terminated by the Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI”
• A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI
  NCT01322815 · TERMINATED · slow enrollment
  “Poor accrual rate”
• Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
  NCT01163526 · TERMINATED · slow enrollment
  “accrual”
• Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver
  NCT00766220 · WITHDRAWN · slow enrollment
  “Slow Accrual and withdrawn/exclusion of 2 participants.”
• Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment
  NCT00126867 · TERMINATED · slow enrollment
  “Insufficient accrual and no funding”
• Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
  NCT00003485 · TERMINATED · slow enrollment
  “slow accrual”

Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.